These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19846907)
1. Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer. Gee JR; Burmeister CB; Havighurst TC; Kim K Anticancer Res; 2009 Oct; 29(10):3769-75. PubMed ID: 19846907 [TBL] [Abstract][Full Text] [Related]
2. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells. Huang KH; Kuo KL; Chen SC; Weng TI; Chuang YT; Tsai YC; Pu YS; Chiang CK; Liu SH PLoS One; 2012; 7(3):e33615. PubMed ID: 22438966 [TBL] [Abstract][Full Text] [Related]
5. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s). Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143 [TBL] [Abstract][Full Text] [Related]
6. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2. Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094 [TBL] [Abstract][Full Text] [Related]
8. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Liu DB; Hu GY; Long GX; Qiu H; Mei Q; Hu GQ Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904 [TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo. Li W; Jiang HR; Xu XL; Wang J; Zhang J; Liu ML; Zhai LY Int J Mol Sci; 2010 Oct; 11(10):3999-4013. PubMed ID: 21152316 [TBL] [Abstract][Full Text] [Related]
12. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism]. Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464 [TBL] [Abstract][Full Text] [Related]
14. Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression. Chan CM; Ma BB; Wong SC; Chan AT Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S268-71. PubMed ID: 16507390 [TBL] [Abstract][Full Text] [Related]
15. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Xiao H; Zhang Q; Lin Y; Reddy BS; Yang CS Int J Cancer; 2008 May; 122(9):2115-24. PubMed ID: 18172863 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Dhawan D; Jeffreys AB; Zheng R; Stewart JC; Knapp DW Mol Cancer Ther; 2008 Apr; 7(4):897-904. PubMed ID: 18413803 [TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy. Kang KB; Zhu C; Yong SK; Gao Q; Wong MC Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164 [TBL] [Abstract][Full Text] [Related]
18. Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms. Liu B; Wen JK; Li BH; Fang XM; Wang JJ; Zhang YP; Shi CJ; Zhang DQ; Han M Cell Death Dis; 2011 Jul; 2(7):e185. PubMed ID: 21796157 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Kardosh A; Blumenthal M; Wang WJ; Chen TC; Schönthal AH Cancer Biol Ther; 2004 Jan; 3(1):55-62. PubMed ID: 14726653 [TBL] [Abstract][Full Text] [Related]
20. Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K. Kim MS; Kim JE; Lim DY; Huang Z; Chen H; Langfald A; Lubet RA; Grubbs CJ; Dong Z; Bode AM Cancer Prev Res (Phila); 2014 Feb; 7(2):236-45. PubMed ID: 24327721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]